The Treatment Effect of an ACE-Inhibitor Based Regimen with Perindopril in Relation to Beta-Blocker use in 29,463 Patients with Vascular Disease: a Combined Analysis of Individual Data of ADVANCE, EUROPA and PROGRESS Trials

Brugts J. J.; Bertrand M.; Remme W.; Ferrari R.; Fox K.; MacMahon S.; Chalmers J.; Simoons M. L.; Boersma E.

首页> 外文期刊>Cardiovascular drugs and therapy >The Treatment Effect of an ACE-Inhibitor Based Regimen with Perindopril in Relation to Beta-Blocker use in 29,463 Patients with Vascular Disease: a Combined Analysis of Individual Data of ADVANCE, EUROPA and PROGRESS Trials

【24h】

The Treatment Effect of an ACE-Inhibitor Based Regimen with Perindopril in Relation to Beta-Blocker use in 29,463 Patients with Vascular Disease: a Combined Analysis of Individual Data of ADVANCE, EUROPA and PROGRESS Trials

机译：基于肝肾上普利的Ace抑制剂方案与β-阻滞剂在29,463例血管疾病患者中使用的治疗效果：提前，欧罗巴和进步试验的个体数据的综合分析

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

In everyday practice, angiotensin converting enzyme inhibitors and beta-blockers are cornerstone treatments in patients with (cardio-)vascular disease. Clear data that evaluate the effects of the combination of these agents on morbidity and mortality are lacking.

机译：在日常做法中，血管紧张素转化酶抑制剂和β受体阻滞剂是（心脏 - ）血管疾病患者的基石治疗。缺乏清除评估这些药物组合对发病率和死亡率的影响的数据。

著录项

来源
《Cardiovascular drugs and therapy》 |2017年第4期|共10页
作者
Brugts J. J.; Bertrand M.; Remme W.; Ferrari R.; Fox K.; MacMahon S.; Chalmers J.; Simoons M. L.; Boersma E.;
展开▼
作者单位

Erasmus Univ Dept Cardiol Thoraxctr Med Ctr S Gravendijkwal 230 NL-3015 CE Rotterdam;

Inst COEUR Poumon Lille France;

STICARES Cardiovasc Res Inst Rhoon Netherlands;

Univ Ferrara Ctr Cardiol Univ Ferrara Italy;

Imperial Coll NHLI London England;

Royal Prince Alfred Hosp George Inst Global Hlth Sydney NSW Australia;

Royal Prince Alfred Hosp George Inst Global Hlth Sydney NSW Australia;

Erasmus Univ Dept Cardiol Thoraxctr Med Ctr S Gravendijkwal 230 NL-3015 CE Rotterdam;

Erasmus Univ Dept Cardiol Thoraxctr Med Ctr S Gravendijkwal 230 NL-3015 CE Rotterdam;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药学;
关键词
ACE-inhibitor; Perindopril; Beta-blocker; Hypertension; Prevention; Vascular disease;

机译：ACE-抑制剂;Perindoplil;β-窝囊;高血压;预防;血管疾病;

相似文献

外文文献
专利

1. The Treatment Effect of an ACE-Inhibitor Based Regimen with Perindopril in Relation to Beta-Blocker use in 29,463 Patients with Vascular Disease: a Combined Analysis of Individual Data of ADVANCE, EUROPA and PROGRESS Trials [J] . Brugts J. J., Bertrand M., Remme W., Cardiovascular drugs and therapy . 2017,第4期

机译：基于肝肾上普利的Ace抑制剂方案与β-阻滞剂在29,463例血管疾病患者中使用的治疗效果：提前，欧罗巴和进步试验的个体数据的综合分析
2. The consistency of the treatment effect of an ACE-inhibitor based treatment regimen in patients with vascular disease or high risk of vascular disease: a combined analysis of individual data of ADVANCE, EUROPA, and PROGRESS trials. [J] . Brugts JJ, Ninomiya T, Boersma E, European Heart Journal: The Journal of the European Society of Cardiology . 2009,第11期

机译：基于血管紧张素转换酶抑制剂的治疗方案在血管疾病或高血管疾病风险患者中的治疗效果的一致性：对ADVANCE，EUROPA和PROGRESS试验的个体数据进行综合分析。
3. The consistency of the treatment effect of an ACE-inhibitor based treatment regimen in patients with vascular disease or high risk of vascular disease: a combined analysis of individual data of ADVANCE, EUROPA, and PROGRESS trials [J] . Jasper J. Brugts1* Toshiharu Ninomiya2 Eric Boersma1 Willem J. Remme3 Michel Bertrand4 Roberto Ferrari5 Kim Fox6 Stephen MacMahon2 John Chalmers2 and Maarten L. Simoons1 European Heart Journal . 2009,第11期

机译：基于血管紧张素转换酶抑制剂的治疗方案在血管疾病或高血管疾病风险患者中的治疗效果的一致性：对ADVANCE，EUROPA和PROGRESS试验的个体数据进行综合分析
4. Development and testing of prediction models for end stage kidney disease patient nonadherence to renal replacement treatment regimens utilizing big data and healthcare informatics [C] . Yue Jiao, Geary Dan, Chaudhuri Sheetal, IEEE International Conference on Bioinformatics and Biomedicine . 2015

机译：利用大数据和医疗信息学开发和测试终末期肾病患者不遵守肾脏替代治疗方案的预测模型
5. Evidence-based treatment for individuals: Role of subgroup analysis and n-of-1 trials [D] . Gabler, Nicole Bloser 2010

机译：个体的循证治疗：亚组分析和N-1次试验的作用
6. The Treatment Effect of an ACE-Inhibitor Based Regimen with Perindopril in Relation to Beta-Blocker use in 29463 Patients with Vascular Disease: a Combined Analysis of Individual Data of ADVANCE EUROPA and PROGRESS Trials [O] . J. J. Brugts, M. Bertrand, W. Remme, -1

机译：培哚普利基于ACE抑制剂的治疗方案对29463例血管疾病患者的β-受体阻滞剂使用的影响：结合ADVANCEEUROPA和PROGRESS试验的个人数据进行分析
7. The Treatment Effect of an ACE-Inhibitor Based Regimen with Perindopril in Relation to Beta-Blocker use in 29,463 Patients with Vascular Disease: a Combined Analysis of Individual Data of ADVANCE, EUROPA and PROGRESS Trials [O] . Brugts, Jasper, Bertrand, Michel, Remme, Willem, 2017

机译：培哚普利基于ACE抑制剂的治疗方案对29,463例血管疾病患者的β-受体阻滞剂使用的影响：结合ADVANCE，EUROPA和PROGRESS试验的个人数据进行分析

The Treatment Effect of an ACE-Inhibitor Based Regimen with Perindopril in Relation to Beta-Blocker use in 29,463 Patients with Vascular Disease: a Combined Analysis of Individual Data of ADVANCE, EUROPA and PROGRESS Trials

摘要

著录项

相似文献

相关主题

期刊订阅